Bottom Article Ad

Wednesday, February 16, 2022

Global Proton Pump Inhibitors Market to be Driven by Rise in the Prevalence of Gastrointestinal Disorders in the Forecast Period of 2022-2027


The new report by Expert Market Research titled, ‘Global Proton Pump Inhibitors Market Report and Forecast 2022-2027’, gives in-depth analysis of the global proton pump inhibitors market, assessing the market based on its segments like drug type and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.

Get a Free Sample Report with Table of Contents:

The key highlights of the report include:

Market Overview (2017-2027): –

  • Forecast Market Size (2027): USD 3.26 Billion

The rise in the geriatric population having stomach problems and increasing prevalence of gastrointestinal disorders and gastroesophageal reflux disease owing to unhealthy diet patterns and increasing sedentary work culture are the major factors driving the global proton pump inhibitor market to industry progress over the projected period. GERD affects people of all ages, but those who have asthma are more likely to get it. Additionally, the rising prevalence of peptic ulcers and gastric acid disorders, as well as the increasing demand for new delivery technologies, are propelling the market forward.

Industry Definition and Major Segments

Proton pump inhibitors (PPIs) are a class of medications that function by inhibiting the generation of acid in the stomach’s lining cells. They are marketed under numerous brand names and include esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole.

Read Full Report with Table of Contents:

The industry can be broadly categorised based on its product types into:

  • OTC Drugs
  • Prescription Drugs

Based on region, the market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Market Trends

The rising incidence of obesity in adults and adolescents is associated with a variety of gastroesophageal reflux disease (GERD)-related disorders, including Barrett’s oesophagus (BE), esophageal erosions, and esophageal cancer. Additionally, the rising prevalence of gastrointestinal illnesses such as duodenal ulcers, Barrett’s oesophagus, and non-erosive reflux disease (NERD) is likely to propel the worldwide proton pump inhibitor market. According to a report issued in July 2020 by the US National Library of Medicine, more than 60% of Americans suffer from non-erosive reflux disease (NERD), and 30% suffer from barrets oesophagus. Esomeprazole is one of the most profitable pharmaceuticals on the market, and it is primarily used to treat the symptoms of GERD, heartburn, and other conditions characterised by an excess of stomach acids. The transition from a prescription-only to an over-the-counter (OTC) drug is likely to be a major driver of the drug’s sales in the near future. Additionally, prominent market players are concentrating their efforts on research and development and market expansion activities in order to deliver innovative and trustworthy formulations to market. For example, in July 2020, Cadila Pharmaceuticals launched esomeprazole tablets in India under the brand name Esiloc for the treatment of hyperacidity and drug-induced gastritis. As a result of the aforementioned factors, the Esomeprazole segment is likely to experience rapid expansion.

Key Market Players

The major players in the market are AstraZeneca plc, Bayer AG, Eli Lilly and Company, Eisai Inc., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Santarus Inc., Takeda Pharmaceuticals, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Media Contact

Company Name: EMR Inc.
Contact Person:- Shira Ellis, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Read More Reports:

Global Critical Care Antiarrhythmic Drugs Market Outlook:

Global Pharmacovigilance Market Outlook:

Global Vaccine Market Outlook:

Global Immunotherapy Drugs Market Outlook:

Global Antiviral Drugs Market Outlook:

Explore more on Procurement Intelligence services of EMR Inc.

**We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.


Post a Comment